6 août 2020 - RCT - HCQ as Postexposure Prophylaxis for Covid-19
Description:
These are just the highlights. I encourage you to read the article.Randomized Controlled Trial:
"We enrolled adults who had household or occupational exposure..."
"...we randomly assigned participants to receive either placebo or hydroxychloroquine"
"After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure." [23]
Ajouté au bande de temps:
Date:
6 août 2020
Maintenaint
~ Il y a 4 ans et 10 mois